[Hospital-associated MRSA -- A current international study overview on practiced infection control measures (2.)].
Panknin
Hardy-Thorsten
HT
ht.panknin@berlin.de
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000627:therapeutic use; D018562:Disease Transmission, Infectious; D005858:Germany; D017575:Gloves, Protective; D006235:Hand Disinfection; D006760:Hospitalization; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D017053:Infection Control / Q000379:methods*; D007362:Intensive Care Units; D007363:Intensive Care Units, Neonatal; D055624:Methicillin-Resistant Staphylococcus aureus / Q000302:isolation & purification; D016712:Mupirocin / Q000008:administration & dosage / Q000627:therapeutic use; D009666:Nose / Q000382:microbiology; D010356:Patient Isolation; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D018805:Sepsis / Q000175:diagnosis / Q000517:prevention & control; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control
D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D016712:Mupirocin